CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-11 | Norry Elliot Chief Medical Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2024-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,945 | $0.84 | $10K | 18,395 |
| 2023-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,403 | $0.78 | $2K | 3,449 |
| 2023-08-01 | Lunger John Chief Patient Supply Officer | Sale | −3,096 | $0.91 | $3K | 4,718 |
| 2023-07-10 | Menzel Garry E Director | Sale | −47,702 | $0.91 | $43K | 75,056 |
| 2023-07-05 | Hegde Priti Director | Grant or award · Option to Purchase Ordinary Shares | +226,464 | 226,464 | ||
| 2023-07-05 | Hegde Priti Director | Grant or award · Option to Purchase Ordinary Shares | +109,746 | 109,746 | ||
| 2023-07-05 | Hegde Priti Director | Grant or award · Option to Purchase Ordinary Shares | +152,376 | 152,376 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +73,212 | 73,212 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +56,868 | 56,868 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +45,348 | 45,348 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +109,746 | 109,746 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +109,746 | 109,746 | ||
| 2023-07-05 | Allen Andrew R Director | Grant or award · Option to Purchase Ordinary Shares | +152,376 | 152,376 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +736,548 | 736,548 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +1,251,966 | 1,251,966 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +359,700 | 359,700 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +3,568,026 | 3,568,026 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +57,846 | 57,846 | ||
| 2023-07-05 | Menzel Garry E Director | Grant or award · Option to Purchase Ordinary Shares | +2,715,816 | 2,715,816 |
Page 5 of 23 · 454 trades